Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roshi

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Journal of Medicinal Chemistry|May 5, 2026
Discovery of MK-1088 as a Potent A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Dual-Antagonist for Cancer ImmunotherapyYonglian Zhang, Elisabeth Hennessy, Matthew A Larsen, et al.
Scientific Reports|January 28, 2018
Low Altitude Solar Magnetic Reconnection, Type III Solar Radio Bursts, and X-ray EmissionsI H Cairns, V V Lobzin, A Donea, et al.
Journal of Medical Virology|November 29, 2022
Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)Seung Hyun Park, Sung Hwi Hong, Kwanghyun Kim, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Journal of Medicinal Chemistry|May 5, 2026
Discovery of MK-1088 as a Potent A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Dual-Antagonist for Cancer ImmunotherapyYonglian Zhang, Elisabeth Hennessy, Matthew A Larsen, et al.
Scientific Reports|January 28, 2018
Low Altitude Solar Magnetic Reconnection, Type III Solar Radio Bursts, and X-ray EmissionsI H Cairns, V V Lobzin, A Donea, et al.
Journal of Medical Virology|November 29, 2022
Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)Seung Hyun Park, Sung Hwi Hong, Kwanghyun Kim, et al.
Pageof 12